Search Results for "Http Clinicaltrials Gov Show Nct00527228"
Matching Channels
PKC (protein kinase C) http://www.bioportfolio.com/channels/serine-threonine-protein-kinase-c-pkc is a kinase enzyme and a protein molecule that can change the format of other proteins through chemi...
Myc is the protein encoded by the MYC gene that activates the cell cycle
Myc is the protein encoded by the MYC gene that activates the cell cycle. It promotes cell replication through genetic coding for p14, inhibiting MDM2 and preventing the degradation of the pro-apopt...
APC stands for adenomatous polyposis coli, a form of colorectal cancer and is a tumour suppressor
APC stands for adenomatous polyposis coli, a form of colorectal cancer and is a tumour suppressor. When APC it mutated, it can cause this particular type of colorectal cancer. When not present in it...
Tumor Immunology is a field of medical science developing to understand tumors, and use the body natural immune system to develop new anti-cancer treatments. Cancer is arguably one of the most impor...
Interleukin 6 IL 6 Receptor IL 6R
Although the causes of rheumatoid arthritis are not fully understood, constitutive overproduction of interleukin-6 (IL-6), a multifunctional cytokine that regulates immune response, inflammatory react...
Matching News
FDA takes on oversight of ClinicalTrials.gov
The US FDA will make sure data in ClinicalTrials.gov is genuine from now on after the HHS delegated the job to the agency.
21-month publication lag found with ClinicalTrials.gov studies
21-month publication lag found with ClinicalTrials.gov studies
Sosei Group Corporation: QVA149 Filed as a Once-Daily Maintenance Treatment for COPD in Europe
TOKYO, October 25, 2012 /PRNewswire/ -- Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565) confirms the information released today by Novartis that QVA149, (indacaterol maleate / glycopyrroni...
US bill seeks tighter reporting requirements for ClinicalTrials.gov
US bill seeks tighter reporting requirements for ClinicalTrials.gov
Innate Pharma: Phase I Clinical Trial of IPH2102/BMS-986015 in Combination With Ipilimumab Announced
MARSEILLES, FRANCE -- (Marketwire) -- 12/19/12 -- Innate Pharma SA (the "Company") (EURONEXT PARIS: IPH) (FR0010331421), the innate immunity company developing first-in-class drugs for cancer and inf...
New Method Promotes Detection of Blinding Eye Disease
MCHENRY, Ill., Jan. 7, 2013 /PRNewswire/ -- There is a disease that is ruining the vision of over a hundred thousand young people in the U.S. who go undiagnosed and untreated. Most don't even know its...
Life Extension Foundation® Sponsors Magnesium Sulfate Study at University of Miami
FORT LAUDERDALE, Fla., July 11, 2012 /PRNewswire/ -- Fort Lauderdale, Fla.-based Life Extension Foundation, a pioneer in funding the latest anti-aging research and integrative health therapies, is spo...
Dr. Steven Shoshany Invited to Appear on the Dr. Oz Show for the Third Time.
NYC Chiropractor Dr. Shoshany has been invited to appear on the Dr. Oz show to talk about Cold Laser therapy. This marks his third appearance on the show.New York, NY (PRWEB) December 19, 2012 Dr Shos...
Matching PubMed Articles
BACKGROUND: The openEHR project and the closely related ISO 13606 standard have defined structures supporting the content of Electronic Health Records (EHRs). However, there is not yet any finalized o...
Abstract Objective: Vilazodone is a novel serotonin reuptake inhibitor and serotonin 1A receptor partial agonist approved for the treatment of major depressive disorder (MDD). This evaluation pre...
The ClinicalTrials.gov results database.
